BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McFarland LV, Ship N, Auclair J, Millette M. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence. J Hosp Infect 2018;99:443-52. [PMID: 29702133 DOI: 10.1016/j.jhin.2018.04.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Rauseo AM, Hink T, Reske KA, Seiler SM, Bommarito KM, Fraser VJ, Burnham CD, Dubberke ER; CDC Prevention Epicenter Program. A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization. Infect Control Hosp Epidemiol 2021;:1-7. [PMID: 33820576 DOI: 10.1017/ice.2021.94] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nagamine T. Primary prevention of Clostridioides difficile infection with combination probiotics. J Hosp Infect 2020;104:80-1. [PMID: 31639419 DOI: 10.1016/j.jhin.2019.10.014] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Steele MI, Motta EVS, Gattu T, Martinez D, Moran NA. The Gut Microbiota Protects Bees from Invasion by a Bacterial Pathogen. Microbiol Spectr 2021;9:e0039421. [PMID: 34523998 DOI: 10.1128/Spectrum.00394-21] [Reference Citation Analysis]
4 Fijan S, Frauwallner A, Langerholc T, Krebs B, Ter Haar Née Younes JA, Heschl A, Mičetić Turk D, Rogelj I. Efficacy of Using Probiotics with Antagonistic Activity against Pathogens of Wound Infections: An Integrative Review of Literature. Biomed Res Int 2019;2019:7585486. [PMID: 31915703 DOI: 10.1155/2019/7585486] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
5 Qin D, Bai Y, Li Y, Huang Y, Li L, Wang G, Qu Y, Wang J, Yu L, Hou X. Changes in Gut Microbiota by the Lactobacillus casei Anchoring the K88 Fimbrial Protein Prevented Newborn Piglets From Clinical Diarrhea. Front Cell Infect Microbiol 2022;12:842007. [DOI: 10.3389/fcimb.2022.842007] [Reference Citation Analysis]
6 Ship N, Carrière S. Going back to prospectively collected results with a probiotic for primary prevention of Clostridium difficile infection at a tertiary-care medical center. Infect Control Hosp Epidemiol 2018;39:1392-3. [PMID: 30289097 DOI: 10.1017/ice.2018.205] [Reference Citation Analysis]
7 Mi H, Bao R, Xiao Y, Cui Y, Sun W, Shen Y, Shi Q, Chen X, Lin J, Hu B, Gao X. Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study. Front Cell Infect Microbiol 2020;10:12. [PMID: 32083021 DOI: 10.3389/fcimb.2020.00012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Maziade PJ, Ship N, Sniffen JC, Goldstein EJC. Enhanced Clostridioides difficile infection prevention with a pharmacy-controlled policy that adds a three-strain Lactobacillus probiotic concomitantly to antibiotic therapy. Clin Infect Dis 2021:ciab414. [PMID: 33966076 DOI: 10.1093/cid/ciab414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bai Y, Huang Y, Li Y, Zhang B, Xiao C, Hou X, Yu L. The Murine Reg3a Stimulated by Lactobacillus casei Promotes Intestinal Cell Proliferation and Inhibits the Multiplication of Porcine Diarrhea Causative Agent in vitro. Front Microbiol 2021;12:675263. [PMID: 34220758 DOI: 10.3389/fmicb.2021.675263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li XY, Li LX, Li Y, Zhou RC, Li B, Gu X, Fu SC, Jin BY, Zuo XL, Li YQ. Complete genome sequencing of Peyer's patches-derived Lactobacillus taiwanensis CLG01, a potential probiotic with antibacterial and immunomodulatory activity. BMC Microbiol 2021;21:68. [PMID: 33639835 DOI: 10.1186/s12866-021-02127-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yokoyama Y, Shiota A, Asai N, Koizumi Y, Yamagishi Y, Sakanashi D, Nakamura A, Suematsu H, Ohnishi M, Mikamo H. Risk factors of first recurrence of Clostridioides difficile infection. Anaerobe 2022;:102556. [PMID: 35395406 DOI: 10.1016/j.anaerobe.2022.102556] [Reference Citation Analysis]
12 Manus J, Millette M, Uscanga BRA, Salmieri S, Maherani B, Lacroix M. In vitro protein digestibility and physico-chemical properties of lactic acid bacteria fermented beverages enriched with plant proteins. J Food Sci 2021. [PMID: 34333773 DOI: 10.1111/1750-3841.15859] [Reference Citation Analysis]
13 Vazquez-Munoz R, Dongari-Bagtzoglou A. Anticandidal Activities by Lactobacillus Species: An Update on Mechanisms of Action. Front Oral Health 2021;2:689382. [PMID: 35048033 DOI: 10.3389/froh.2021.689382] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ballini A, Santacroce L, Cantore S, Bottalico L, Dipalma G, Topi S, Saini R, De Vito D, Inchingolo F. Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study. Endocr Metab Immune Disord Drug Targets 2019;19:373-81. [PMID: 30574857 DOI: 10.2174/1871530319666181221150352] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
15 Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, Abu-Zidan FM, Ansaloni L, Augustin G, Bala M, Ben-Ishay O, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cortese F, Cui Y, Czepiel J, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckmann C, Eiland EH, Forrester JD, Fraga GP, Frossard JL, Fry DE, Galeiras R, Ghnnam W, Gomes CA, Griffiths EA, Guirao X, Ahmed MH, Herzog T, Kim JI, Iqbal T, Isik A, Itani KMF, Labricciosa FM, Lee YY, Juang P, Karamarkovic A, Kim PK, Kluger Y, Leppaniemi A, Lohsiriwat V, Machain GM, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Ordoñez CA, Pagani L, Petrosillo N, Portela F, Rasa K, Rems M, Sakakushev BE, Segovia-Lohse H, Sganga G, Shelat VG, Spigaglia P, Tattevin P, Tranà C, Urbánek L, Ulrych J, Viale P, Baiocchi GL, Catena F. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg 2019;14:8. [PMID: 30858872 DOI: 10.1186/s13017-019-0228-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 15.7] [Reference Citation Analysis]
17 Sakandar HA, Zhang H. Trends in Probiotic(s)-Fermented milks and their in vivo functionality: A review. Trends in Food Science & Technology 2021;110:55-65. [DOI: 10.1016/j.tifs.2021.01.054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Sniffen JC, McFarland LV, Evans CT, Goldstein EJC. Choosing an appropriate probiotic product for your patient: An evidence-based practical guide. PLoS One 2018;13:e0209205. [PMID: 30586435 DOI: 10.1371/journal.pone.0209205] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
19 Ship N, Millette M, Carrière S. Rhetoric or Rhetoric: Interpreting Cross-Sectional Data When There Are Disparate Control Groups. Open Forum Infect Dis 2019;6:ofz127. [PMID: 31041342 DOI: 10.1093/ofid/ofz127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 McFarland LV, Johnson SB, Evans CT. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence. Am J Infect Control 2021;49:375-84. [PMID: 32791261 DOI: 10.1016/j.ajic.2020.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Sheffield ME, Jones BM, Terrell B, Wagner JL, Bland CM. Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones. Pharmacy (Basel) 2021;9:141. [PMID: 34449745 DOI: 10.3390/pharmacy9030141] [Reference Citation Analysis]
22 Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol 2021; 27(42): 7210-7232 [PMID: 34876784 DOI: 10.3748/wjg.v27.i42.7210] [Reference Citation Analysis]
23 Wu Y, Wang L, Luo R, Chen H, Nie C, Niu J, Chen C, Xu Y, Li X, Zhang W. Effect of a Multispecies Probiotic Mixture on the Growth and Incidence of Diarrhea, Immune Function, and Fecal Microbiota of Pre-weaning Dairy Calves. Front Microbiol 2021;12:681014. [PMID: 34335503 DOI: 10.3389/fmicb.2021.681014] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Romyasamit C, Thatrimontrichai A, Aroonkesorn A, Chanket W, Ingviya N, Saengsuwan P, Singkhamanan K. Enterococcus faecalis Isolated From Infant Feces Inhibits Toxigenic Clostridioides (Clostridium) difficile. Front Pediatr 2020;8:572633. [PMID: 33102409 DOI: 10.3389/fped.2020.572633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 del Rio B, Redruello B, Fernandez M, Martin MC, Ladero V, Alvarez MA. Lactic Acid Bacteria as a Live Delivery System for the in situ Production of Nanobodies in the Human Gastrointestinal Tract. Front Microbiol 2019;9:3179. [DOI: 10.3389/fmicb.2018.03179] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
26 Ma Y, Yang JY, Peng X, Xiao KY, Xu Q, Wang C. Which probiotic has the best effect on preventing Clostridium difficile-associated diarrhea? A systematic review and network meta-analysis. J Dig Dis 2020;21:69-80. [PMID: 31875427 DOI: 10.1111/1751-2980.12839] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
27 Manus J, Millette M, Dridi C, Salmieri S, Aguilar Uscanga BR, Lacroix M. Protein quality of a probiotic beverage enriched with pea and rice protein. J Food Sci 2021;86:3698-706. [PMID: 34268736 DOI: 10.1111/1750-3841.15838] [Reference Citation Analysis]